For statistical analyses, SPSS v.23 software (SPSS Inc., Chicago, IL,USA) was used.Results: A statistically significant difference was observed for the frequency of the CC genotype between the uterine leiomyoma and controlgroups, and the frequencies of the T allele in the uterine leiomyoma groups were significantly higher than in the control group.Conclusion: The presence of the fok1 CC genotype may be a risk-reducing factor and the T allele may be a potential risk factor for developinguterine leiomyoma. (J Turk Ger Gynecol Assoc 2018; 19: 128-31)
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Objective: The aim of this research was to determine the association between the fok1 polymorphism and uterine leiomyomas.Material and Methods: For genotyping the fok1 polymorphism of the vitamin D receptor, real-time polymerase chain reaction was performedon blood samples of uterine leiomyoma (n=27) and control (n=33) groups.
📊
Key Findings & Data:Objective: The aim of this research was to determine the association between the fok1 polymorphism and uterine leiomyomas.Material and Methods: For genotyping the fok1 polymorphism of the vitamin D receptor, real-time polymerase chain reaction was performedon blood samples of uterine leiomyoma (n=27) and control (n=33) groups.
💡
Conclusion & Impact:For statistical analyses, SPSS v.23 software (SPSS Inc., Chicago, IL,USA) was used.Results: A statistically significant difference was observed for the frequency of the CC genotype between the uterine leiomyoma and controlgroups, and the frequencies of the T allele in the uterine leiomyoma groups were significantly higher than in the control group.Conclusion: The presence of the fok1 CC genotype may be a risk-reducing factor and the T allele may be a potential risk factor for developinguterine leiomyoma. (J Turk Ger Gynecol Assoc 2018; 19: 128-31)
🔬Design:Research Article
📍Scope:2018 Verileri
⚙️Variables:Domain Parameters
Abstract
Objective: The aim of this research was to determine the association between the fok1 polymorphism and uterine leiomyomas.Material and Methods: For genotyping the fok1 polymorphism of the vitamin D receptor, real-time polymerase chain reaction was performedon blood samples of uterine leiomyoma (n=27) and control (n=33) groups. For statistical analyses, SPSS v.23 software (SPSS Inc., Chicago, IL,USA) was used.Results: A statistically significant difference was observed for the frequency of the CC genotype between the uterine leiomyoma and controlgroups, and the frequencies of the T allele in the uterine leiomyoma groups were significantly higher than in the control group.Conclusion: The presence of the fok1 CC genotype may be a risk-reducing factor and the T allele may be a potential risk factor for developinguterine leiomyoma. (J Turk Ger Gynecol Assoc 2018; 19: 128-31)
🔖
Cite This Article
İŞBİR, T., YILMAZ, S. G., YILDIRIM, G., ATTAR, R., GÜL, T. (2022). Association between fok1 polymorphism of vitamin D receptor gene with uterine leiomyoma in Turkish populations. Journal of the Turkish-German Gynecological Association, Cilt: 19 - Sayı: 3, 128–131. https://ajindex.com/articles/567482
Dvorska D, Brany D, Dankova Z, Halasova E, Visnovsky J. Molecular and clinical attributes of uterine leiomyomas. Tumour Biol 2017; 39: 1010428317710226. Jonathan S, Berek NFH. Practical Gynecologic Oncology. In: Jonathan S, Berek MMS, Neville F, Hacker AM, editors. Philadelphia, USA: Lippincott Williams & Wilkins; 2000. p. 208-10.
Brakta S, Diamond JS, Al-Hendy A, Diamond MP, Halder SK. Role of vitamin D in uterine fibroid biology. Fertil Steril 2015; 104: 698- 706. Goodwin MT, Montoro MN, Muderspach L, Paulson R, Roy S. Management of Common Problem in Obstetrics and Gynecology. UK: Wiley-Blackwell; 2010. p. 291-4.
Halder SK, Sharan C, Al-Hendy O, Al-Hendy A. Paricalcitol, a vitamin d receptor activator, inhibits tumor formation in a murine model of uterine fibroids. Reprod Sci 2014; 21: 1108-19.
Rai V, Abdo J, Agrawal S, Agrawal DK. Vitamin D Receptor Polymorphism and Cancer: An Update. Anticancer Res 2017; 37: 3991-4003.
Gündüz M, Cacına C, Toptas B, Yaylim-Eraltan İ, Tekand Y, İsbir T. Association of vitamin D receptor gene polymorphisms with colon cancer. Genet Test Mol Biomarkers 2012; 16: 1058-61.
Taymans SE, Pack S, Pak E, Orban Z, Barsony J, Zhuang Z, et al. The human vitamin D receptor gene (VDR) is localized to region 12cen-q12 by fluorescent in situ hybridization and radiation hybrid mapping: genetic and physical VDR map. J Bone Miner Res 1999; 14: 1163-6. Mocellin S. Vitamin D and cancer: deciphering the truth. Biochim Biophys Acta 2011; 1816: 172-8.
Haussler MR, Whitfield GK, Haussler CA, Hsieh JC, Thompson PD, Selznick SH, et al. The nuclear vitamin D receptor: biological and molecular regulatory properties revealed. J Bone Miner Res 1998; 13: 325-49.
Gross C, Eccleshall TR, Malloy PJ, Villa ML, Marcus R, Feldman D. The presence of a polymorphism at the translation initiation site of the vitamin D receptor gene is associated with low bone mineral density in postmenopausal Mexican-American women. J Bone Miner Res 1996; 11: 1850-5.
Mun MJ, Kim TH, Hwang JY, Jang WC. Vitamin D receptor gene polymorphisms and the risk for female reproductive cancers: A meta-analysis. Maturitas 2015; 81: 256-65.
Baird DD, Hill MC, Schectman JM, Hollis BW. Vitamin d and the risk of uterine fibroids. Epidemiology 2013; 24: 447-53.
Lizcano F, Guzmán G. Estrogen Deficiency and the Origin of Obesity during Menopause. Biomed Res Int 2014; 2014: 757461. Marshall LM, Spiegelman D, Barbieri RL, Goldman MB, Manson JE, Colditz GA, et al. Variation in the incidence of uterine